Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Boundless Bio Inc (BOLD)

Boundless Bio Inc (BOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 27,311
  • Shares Outstanding, K 22,386
  • Annual Sales, $ 0 K
  • Annual Income, $ -65,360 K
  • EBIT $ -68 M
  • EBITDA $ -67 M
  • 60-Month Beta -0.81
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.26

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.44
  • Number of Estimates 1
  • High Estimate -0.44
  • Low Estimate -0.44
  • Prior Year -0.74
  • Growth Rate Est. (year over year) +40.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0000 +22.00%
on 11/26/25
1.3700 -10.95%
on 12/18/25
+0.0700 (+6.09%)
since 11/19/25
3-Month
1.0000 +22.00%
on 11/26/25
1.5500 -21.29%
on 10/22/25
+0.0800 (+7.02%)
since 09/19/25
52-Week
1.0000 +22.00%
on 11/26/25
3.1200 -60.90%
on 01/02/25
-1.3000 (-51.59%)
since 12/19/24

Most Recent Stories

More News
Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference

SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Boundless Bio , (Nasdaq: BOLD) a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to...

BOLD : 1.2200 (-3.94%)
Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights

 Enrollment ongoing in BBI-355 / BBI-825 combination arm of the POTENTIATE trial Investigational new drug submission for BBI-940 on track, with a first-in-human clinical trial expected to initiate...

BOLD : 1.2200 (-3.94%)
Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

SAN DIEGO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Boundless Bio , (Nasdaq: BOLD) a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to...

BOLD : 1.2200 (-3.94%)
Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights

BBI-355 and BBI-825 combination arm of the POTENTIATE trial is now open for enrollment BBI-940 is on track for submission of an investigational new drug application in the first half of...

BOLD : 1.2200 (-3.94%)
Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

BOLD : 1.2200 (-3.94%)
Boundless Bio Announces Portfolio Prioritization and Runway Extension

BOLD : 1.2200 (-3.94%)
Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights

BOLD : 1.2200 (-3.94%)
New Strong Sell Stocks for May 1st

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:Amplify Energy AMPY is an oil and natural gas company which is engaged in the acquisition, development, exploration and production...

BOLD : 1.2200 (-3.94%)
AMPY : 4.75 (+3.49%)
ASTS : 75.84 (+15.03%)
Boundless Bio to Participate in the Needham Virtual Healthcare Conference

BOLD : 1.2200 (-3.94%)
Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

BOLD : 1.2200 (-3.94%)

Business Summary

Boundless Bio Inc. is a clinical stage oncology company interrogating extrachromosomal DNA biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers. Boundless Bio Inc. is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 1.3530
2nd Resistance Point 1.3264
1st Resistance Point 1.2732
Last Price 1.2200
1st Support Level 1.1934
2nd Support Level 1.1668
3rd Support Level 1.1136

See More

52-Week High 3.1200
Fibonacci 61.8% 2.3102
Fibonacci 50% 2.0600
Fibonacci 38.2% 1.8098
Last Price 1.2200
52-Week Low 1.0000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar